BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15764174)

  • 21. Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.
    Al-Tawfiq JA
    Int J Infect Dis; 2007 May; 11(3):239-44. PubMed ID: 16859945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.
    Zaoutis TE; Argon J; Chu J; Berlin JA; Walsh TJ; Feudtner C
    Clin Infect Dis; 2005 Nov; 41(9):1232-9. PubMed ID: 16206095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia.
    Uzun O; Ascioglu S; Anaissie EJ; Rex JH
    Clin Infect Dis; 2001 Jun; 32(12):1713-7. PubMed ID: 11360213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
    Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
    Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fungemia in non-HIV-infected patients: a five-year review.
    Anunnatsiri S; Chetchotisakd P; Mootsikapun P
    Int J Infect Dis; 2009 Jan; 13(1):90-6. PubMed ID: 18653367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
    Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
    Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidemiological study of invasive nosocomial candidiasis in 2 teaching hospitals in Beijing].
    Cao B; Wang H; Wu L; Sun WJ; Li F; Liu YM
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1970-3. PubMed ID: 19062737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple-species candidemia in patients with cancer.
    Boktour MR; Kontoyiannis DP; Hanna HA; Hachem RY; Girgawy E; Bodey GP; Raad II
    Cancer; 2004 Oct; 101(8):1860-5. PubMed ID: 15386338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality associated with systemic candidiasis in children.
    Pacheco-RĂ­os A; Avila-Figueroa C; Nobigrot-Kleinman D; Santos JI
    Arch Med Res; 1997; 28(2):229-32. PubMed ID: 9204614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.
    Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
    Crit Care Med; 2007 Jan; 35(1):146-54. PubMed ID: 17080004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007.
    Nace HL; Horn D; Neofytos D
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):289-94. PubMed ID: 19376670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of risk factors for candidemia versus bacteremia in hospitalized patients.
    Amrutkar PP; Rege MD; Chen H; LaRocco MT; Gentry LO; Garey KW
    Infection; 2006 Dec; 34(6):322-7. PubMed ID: 17180586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology, risk factors for and outcome of candidaemia among non-neutropenic patients in a Greek intensive care unit.
    Pratikaki M; Platsouka E; Sotiropoulou C; Douka E; Paramythiotou E; Kaltsas P; Kotanidou A; Paniara O; Roussos C; Routsi C
    Mycoses; 2011 Mar; 54(2):154-61. PubMed ID: 19793354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of time to antifungal therapy on mortality in Candidemia associated septic shock.
    Patel GP; Simon D; Scheetz M; Crank CW; Lodise T; Patel N
    Am J Ther; 2009; 16(6):508-11. PubMed ID: 19531934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of adverse outcome from candidal infection in a tertiary care hospital.
    Ben-Abraham R; Keller N; Teodorovitch N; Barzilai A; Harel R; Barzilay Z; Paret G
    J Infect; 2004 Nov; 49(4):317-23. PubMed ID: 15474630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candida colonization and candidemia in a pediatric intensive care unit.
    Singhi S; Rao DS; Chakrabarti A
    Pediatr Crit Care Med; 2008 Jan; 9(1):91-5. PubMed ID: 18477920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burden of early-onset candidemia: analysis of culture-positive bloodstream infections from a large U.S. database.
    Shorr AF; Gupta V; Sun X; Johannes RS; Spalding J; Tabak YP
    Crit Care Med; 2009 Sep; 37(9):2519-26; quiz 2535. PubMed ID: 19623050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic indices of diabetes mortality.
    Ogbera AO; Chinenye S; Onyekwere A; Fasanmade O
    Ethn Dis; 2007; 17(4):721-5. PubMed ID: 18072385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan.
    Chen TC; Chen YH; Tsai JJ; Peng CF; Lu PL; Chang K; Hsieh HC; Chen TP
    J Microbiol Immunol Infect; 2005 Jun; 38(3):200-10. PubMed ID: 15986071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.